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In Vivo Interaction Proteomics in
Caenorhabditis elegans Embryos Provides
New Insights into P Granule Dynamics*□S
Jia-Xuan Chen‡§, Patricia G. Cipriani§¶, Desirea Mecenas§, Jolanta Polanowska§,
Fabio Piano§¶, Kristin C. Gunsalus§¶‡‡, and Matthias Selbach‡**‡‡
Studying protein interactions in whole organisms is fun-
damental to understanding development. Here, we com-
bine in vivo expressed GFP-tagged proteins with quanti-
tative proteomics to identify protein-protein interactions
of selected key proteins involved in early C. elegans em-
bryogenesis. Co-affinity purification of interaction part-
ners for eight bait proteins resulted in a pilot in vivo
interaction map of proteins with a focus on early devel-
opment. Our network reflects known biology and is highly
enriched in functionally relevant interactions. To demon-
strate the utility of the map, we looked for new regulators
of P granule dynamics and found that GEI-12, a novel bind-
ing partner of the DYRK family kinase MBK-2, is a key
regulator of P granule formation and germlinemaintenance.
Our data corroborate a recently proposed model in which
the phosphorylation state of GEI-12 controls P granule dy-
namics. In addition, we find that GEI-12 also induces gran-
ule formation in mammalian cells, suggesting a common
regulatory mechanism in worms and humans. Our results
show that in vivo interaction proteomics provides unique
insights into animal development. Molecular & Cellular
Proteomics 15: 10.1074/mcp.M115.053975, 1642–1657,
2016.
Protein-protein interactions (PPIs)1 are central to virtually all
aspects of life. The systematic characterization of all PPIs is
therefore a major goal and challenge in the post genomic era.
Large scale in vitro screens using cell lines or the yeast
two-hybrid system have generated protein interaction maps
that can help to better understand the functional organization
of the proteome (1–9). Despite their effectiveness, such in
vitro experiments cannot reflect all aspects of the complex
interplay of proteins from whole organisms or tissues. For
example, because proteins are often expressed in a tissue-
and stage-dependent manner during the development of a
multicellular organism, experiments in cell lines or heterolo-
gous systems can result in the identification of interaction
partners that are not biologically relevant in a physiologic
context. Similarly, many PPIs are regulated by condition-
specific post-translational modifications, which may not be
adequately represented in yeast or cell-based assay systems.
These limitations provide compelling reasons to develop ap-
proaches that can capture the endogenous interaction part-
ners of proteins within a living organism.
During embryogenesis, PPIs play key roles in directing and
coordinating essential developmental processes. A well-
known example is the interaction between the scaffold pro-
teins PAR-3 and PAR-6 with the atypical protein kinase C
(aPKC) PKC-3, whose family members are required to estab-
lish polarity across the animal kingdom (10, 11). In C. elegans
embryos, this polarity pathway induces the asymmetric dis-
tribution of microscopically visible aggregates of RNAs and
proteins, so called P granules. In the one-cell embryo, P
granules localize to the posterior and subsequently segregate
to the germline progenitor via successive asymmetric cell
divisions. Mutations in genes encoding P granule components
often cause sterility, indicating that they are key determinants
of germ cell identity (12). P granules display liquid-like prop-
erties and localize via controlled dissolution and condensation
(13). However, the signaling events mediating the dynamics of
P granules (and other types of ribonucleoprotein (RNP) gran-
ules) are not yet completely understood.
Affinity purification and mass spectrometry (AP-MS) is
emerging as a useful technology to map PPIs based on whole
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organisms or tissues. Pioneering work by Cheeseman and
co-workers applied this strategy to define interaction partners
of kinetochore proteins in C. elegans (14, 15). A major chal-
lenge in such experiments is the trade-off between sensitivity
and specificity. On the one hand, mild purification conditions
preserve transient interactions but also lead to a high number
of nonspecific contaminants. On the other hand, stringent
purification procedures, such as tandem affinity purification
(TAP), reduce nonspecific binding but could lead to loss of
transient interactions. Most published studies did not employ
quantification, which makes it difficult to distinguish genuine
interaction partners from nonspecific contaminants (15–18).
Quantitative affinity purification and mass spectrometry
solves this problem by using quantification as an additional
filter (19–21). Here, the abundance of proteins coprecipitating
with the bait protein under mild conditions is compared with a
suitable control experiment. Specific interaction partners can
then be identified by their high abundance ratio. For example,
this approach has been used to identify interaction partners of
GFP-fusion proteins in tissue culture cells (22). This eliminates
the need for extensive purification and greatly increases the
confidence in the data. However, so far this was largely lim-
ited to the analysis of single bait proteins in vivo (23, 24). To
our knowledge, the approach has not yet been employed for
systematic in vivo PPI mapping in C. elegans early embryos.
Here, we use mass spectrometry-based quantitative pro-
teomics to identify interaction partners of eight proteins in-
volved in multiple aspects of C. elegans early embryogenesis.
Our interaction network reflects known biology and is highly
enriched in interacting proteins that share related phenotypes
and functional annotations. We followed up on the biological
role of the novel MBK-2 interaction partner GEI-12 and show
that GEI-12 and its paralog are key regulators of P granule
assembly. Our results are also supported by a recent report in
which MBK-2 was found to phosphorylate GEI-12 in vitro and
the in vivo phosphorylation level of the protein was affected by
MBK-2 and PPTR-1 (25). Additionally, we demonstrated that
MBK-2 is physically associated with both GEI-12 and PPTR-2
in embryos and that GEI-12 forms RNP granules when ex-
pressed in mammalian cells. In summary, our data show that
quantitative in vivo interaction proteomics provides unique
insights into protein function during development.
EXPERIMENTAL PROCEDURES
C. elegans Culture and Strains—C. elegans strains were cultured
on OP50 seeded NGM plates using standard techniques as previ-
ously described (26). SILAC worm culture was performed as reported
(27). Briefly, peptone-free NGM plates containing antibiotic-antimy-
cotic (Invitrogen, Carlsbad, CA) were seeded with a lysine-auxotrophic
E. coli strain AT713 metabolically labeled with either Lys-0: L-lysine-
12C6
14N2 (‘light’) or Lys-8: L-lysine-
13C6
15N2 (‘heavy’). Synchronized
L1 larvae were added to the seeded plates and grown for one
generation.
The following strains and mutants were used in this study: Bristol
N2 (wild-type), gei-12(tm4526), gei-12(tm4259), C36C9.1(tm4343),
pptr-1(tm3103)
BS1080 ozIs5[GLD-1::GFP::FLAG; unc-119()] (28)
EK244 cmIs6[MBK-1::GFP; unc-4()] (29)
JH1576 axIs1140[Ppie-1::GFP::MBK-2; unc-119()] (30)
JH2015 axIs1462[Ppie-1::GFP::PIE-1::3pie-1; unc-119()] (31)
JH2017 axIs1464[Ppie-1::GFP::PGL-3::3pgl-3; unc-119()] (31)
JH2166 axIs1567[Ppie-1::GFP::SPN-4::3spn-4; unc-119()] (31)
JH2688 axIs1927[Ppie-1::LAP::GLH-1::3nos-2; unc-119()] (32)
MG170 (zen-4(or153ts) IV; xsEx6[ZEN-4::GFP]) (33)
PF633 nnIs265[Ppie-1::PAR-6::GFP::3pie-1; unc-119()]
PF720 nnIs352[Ppie-1::POS-1::GFP::3pie-1; unc-119()]
PF1207 nnIs795[Pgld-1::GEI-12::GFP::3xFLAG::3unc-54; unc-119()]
SS747 bnIs1[Ppie-1::GFP::PGL-1; unc-119()] (34)
TH120 ([Ppie-1::GFP::PAR-2::3par-2]; [Ppie-1::mCherry::PAR-6::
3pie-1]) (35)
WH346 ojIs34[GFP::CAR-1; unc-119()]
Cloning—Full-length gei-12 was amplified from N2 cDNA using the
GATEWAY forward primer 5-GGGGACAAGTTTGTACAAAAAAGCA-
GGCTTGAGTTCCTCAAAACCTTACCCA-3 and reverse primer
5-GGGGACCACTTTGTACAAGAAAGCTGGGTATTGATCTCTGGGT-
GGGTCAAAAATAG-3, cloned into the pDONR221 vector and sub-
cloned into pCFJ150 vector (36) for microparticle bombardment and
into a pDEST_EGFP destination vector (gift from Markus Landthaler)
for mammalian cell expression. For generating the mbk-2 RNAi clone,
a 1393 bps genomic fragment of mbk-2 was PCR amplified using
forward primer: 5-CGATCACACACATCCTCGTC-3 and reverse
primer: 5-AACCTCATGATCGGCAAGTC-3, TA cloned into the RNAi
feeding vector (L4440) and transformed into HT115 bacteria as de-
scribed (37).
Mammalian Cell Culture and Transfection—HEK293T cells were
maintained in a humidified incubator under 5%CO2 at 37 °C in DMEM
medium supplemented with 10% fetal bovine serum and 4 mM Glu-
taMAX. SILAC cell culture was performed using SILAC DMEM media
containing either (“light”) Lys-0: L-lysine-12C6
14N2, Arg-0: L-arginine-
12C6
14N4 or (“heavy”) Lys-8: L-lysine-
13C6
15N2, Arg-10: L-arginine-
13C6
15N4 and supplemented with 10% dialyzed fetal bovine serum, 4
mM GlutaMAX and 1 mM sodium pyruvate. Cells were transfected
using standard protocols with linear polyethylenimine (PEI) transfec-
tion reagent (Polysciences, Warrington, PA) for pull-down experi-
ments and with Lipofectamine 2000 (Invitrogen) for fluorescence
microscopy.
RNAi and Sterility Assays—Feeding RNAi was performed similar to
previously described (38). Briefly, inoculated RNAi bacterial culture
was grown in LB media containing 50 g/ml ampicillin for 7 h,
followed by IPTG (1 mM) induction for 1 h. The bacterial culture was
then seeded onto NGM plates containing 50 g/ml ampicillin and 1
mM IPTG. Seeded plates were let dry, protected from light and incu-
bated at room temperature overnight. Synchronized L1 larvae were
then added to the seeded plates and were incubated at 25 °C for48
h until F1 embryos could be harvested for further examinations.
For trans-generational feeding and sterility assays, L1 larvae were
subjected to gei-12(RNAi) continuously through adulthood on solid
medium at 15 °C or 25 °C; multiple L1 progeny were individually
transferred to new feeding plates and the process was repeated
through two filial generations. Adults from each generation were
examined individually and scored as sterile if no embryos were visible
in the uterus.
Embryo Immunostaining and Mammalian Cell Fixation—Embryos
were fixed by the freeze-cracking method in liquid nitrogen, followed
by methanol/acetone fixation and rehydration in a descending ace-
tone series modified from Takeda et al. (39). P granules were stained
by monoclonal K76 antibody (1:5 dilution) (40), followed by FITC-
conjugated anti-mouse IgG (1:200, Jackson ImmunoResearch, West
Grove, PA). Slides were mounted using VECTASHIELD mounting
medium with DAPI (Vector Laboratories, Burlingame, CA). Trans-
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fected HEK293T cells were fixed by 4% paraformaldehyde, washed
and briefly stained with DAPI. Slides were mounted using
VECTASHIELD HardSet mounting medium.
Fluorescence Microscopy—Live and fixed embryo fluorescence
imaging and time-lapse microscopy were carried out using a Leica
DM RA2 microscope equipped with a Hamamatsu C9100–12 EM-
CCD camera. Fixed mammalian cell images were acquired with a
Zeiss Axio Imager M2 system. Images were processed in Volocity
(PerkinElmer, Waltham, MA) and ImageJ software (41).
Experimental Design and Statistical Rationale—
Quantitative Affinity Purification Assays—Embryos (2 million per
replicate) were freshly harvested in biological triplicate by bleaching
young gravid hermaphrodites and sonicated on ice (cycle: 0.5 s,
amplitude: 40–45%, 5 strokes/session, 5 sessions, interval between
sessions: 30 s; UP200S ultrasonic processor (Hielscher Ultrasonics
GmbH)) in lysis buffer (total volume: 600 l; 50 mM Tris-HCl, pH 7.4,
100 mM KCl, 1 mM MgCl2, 1 mM EGTA, 1 mM DTT, 10% glycerol,
protease inhibitor mixture (Roche), 0.1% Nonidet P-40 Substitute
(Sigma)). After sonication, Nonidet P-40 Substitute was added up to
1% and the lysates were incubated with head over tail rotation at 4 °C
for 30 min, followed by centrifugation at 20,000 g for 20 min at 4 °C.
Cleared lysate was then aspirated without disturbing the upper lipid
layer and split by half into either the anti-GFP agarose beads or the
blocked control beads (40–50 l, Chromotek) (Fig. 1A). After head
over tail rotation at 4 °C for 60–90 min, the beads were washed once
with lysis buffer containing 0.1% Nonidet P-40 Substitute, followed
by two times of washing in either buffer I (25 mM Tris-HCl, pH 7.4, 300
mM NaCl, 1 mM MgCl2) or buffer II (1 mM Tris-HCl, pH 7.4, 150 mM
NaCl, 1 mM MgCl2) or both. For GFP::MBK-2 pull-downs, two sepa-
rate experiments were performed using different washing conditions.
Proteins were eluted by orbital shaking in 50 l of 6 M urea/2 M
thiourea at room temperature. For the MBK-1::GFP pull-down exper-
iments, proteins were eluted twice by shaking in 50 l of 8 M guani-
dinium chloride at 90 °C, followed by ethanol precipitation. Eluted
protein samples were then digested in-solution as previously reported
(19).
For checking the impact of post-lysis interactions, SILAC-labeled
“light” BS1080 (GLD-1::GFP) young adults were mixed with “heavy”
N2 worms, either before lysis or only at the last washing step before
elution (Fig. 2A). For the samples mixed before the pull-down, lysates
were incubated with anti-GFP agarose beads for 60 min and the
bound proteins were eluted in 6 M urea/2 M thiourea. For the samples
mixed after the pull-down, the incubation time was 30 min and the
elution was performed in 100 mM glycine-HCl, pH 2.5.
For the label-swap SILAC pull-down experiments using HEK293T
cells, the EGFP::GEI-12 expressing cells and the control EGFP-only
expressing cells were lysed separately in lysis buffer (25 mM Tris-HCl,
pH 7.4, 125 mM KCl, 1 mM MgCl2, 1 mM EGTA, 1 mM DTT, 5%
glycerol, protease inhibitor mixture, 1% Triton X-100). Cleared lysates
were incubated with anti-GFP agarose beads at 4 °C for 90 min,
followed by three sequential washes in the following buffers: I (25 mM
Tris-HCl, pH 7.4, 125 mM KCl, 1 mM MgCl2, 1 mM EGTA, 0.1% Triton
X-100), II (25 mM Tris-HCl, pH 7.4, 125 mM KCl, 1 mM MgCl2, 1 mM
EGTA), III (1 mM Tris-HCl, pH 7.4, 150 mM KCl, 1 mM MgCl2). Beads
of the two SILAC states were combined before the final wash. Pro-
teins were eluted using 8 M guanidinium chloride, ethanol precipitated
and further processed as mentioned above. To check whether GEI-12
interactions were partially mediated by RNA, pull-down experiments
against EGFP::GEI-12 were performed using cell lysates pre-treated
with or without nuclease (250 U, Pierce Universal Nuclease, Thermo
Scientific) for 20 min.
Pull-down Simulation Experiment—To simulate the detection of
label-free pull-down enrichment in a complex nonspecific back-
ground, two samples of predefined composition were prepared: sam-
ple 1: 1 E. coli lysate, 1 UPS2 human standard (Sigma Aldrich),
recombinant CDC42 (gift from Florian Paul); sample 2: 1 E. coli
lysate, 4 UPS2 human standard, recombinant RAC1, RHOA, and
GFP. These two samples were measured in succession in triplicate.
Liquid Chromatography Tandem Mass Spectrometry—Peptide
mixtures were separated by reversed phase chromatography using
the Eksigent NanoLC Ultra system or the EASY-nLC system (Thermo
Scientific) on a 20-cm fritless silica microcolumn (inner diameter: 75
m) packed in-house using ReproSil-Pur C18-AQ 3-m resin (Dr.
Maisch GmbH). Peptides were separated on an 8–50% acetonitrile
gradient (120 min or 200 min) with 0.1% formic acid at a nanoflow rate
of 200 nl/min. Eluting peptides were directly ionized by electrospray
ionization and transferred into an LTQ Orbitrap Velos or a Q Exactive
Quadrupole-Orbitrap mass spectrometer (Thermo Scientific). Mass
spectrometry was conducted using data-dependent mode with one
full scan followed by fragmentation scans of the ten most intense ions
using a sensitive method.
Mass Spectrometry Data Analysis—Raw data files were processed
with default settings (unless stated otherwise) in MaxQuant version
1.4.1.2 (42) using the built-in Andromeda search engine (43) against a
target-decoy database containing the forward and reverse sequences:
for embryo pull-downs, WormPep release WS245 (27,368 entries) and
E. coli K-12 MG1655 proteome (4285 entries); for HEK293T cells,
Uniprot human proteome release 201402 (88,665 entries). Common
contaminants (247 entries), such as Keratins, were also included in
the database search. Trypsin/P specificity was used for all data
except for SILAC worm data for which LysC/P specificity was applied.
Carbamidomethylation of cysteine was used as fixed modification;
oxidation of methionine and acetylation of the protein N terminus
were set as variable modifications. Minimal peptide length of 7 amino
acids was required and a maximum of two missed cleavages were
allowed. The “second peptide” option was chosen to decipher co-
fragmented MS/MS spectra. False discovery rate was set to 1% for
both peptide and protein identifications. Each protein group was
required to contain at least one unique peptide. Only the first member
of each protein group was considered for further analysis.
For embryo label-free pull-down experiments, protein quantifica-
tion was performed using the label-free quantification (LFQ) algorithm
(44). Minimum LFQ ratio count was set to one. Both unique and razor
peptides were considered for quantification. Retention times were
recalibrated using the default nonlinear time-rescaling algorithm. The
“match between runs” option was chosen for transferring MS/MS
identifications between LC-MS/MS runs with the maximal retention
time window set to 1 min. Only proteins quantified in at least two out
of the three GFP pull-down replicates were included in the analysis.
LFQ intensities were log2-transformed and imputation for missing
values was performed in Perseus software (version 1.2.0.17) based on
a simulated normal distribution to represent low abundance values
below the noise level (width  0.3; shift  1.8). The LFQ abundance
ratio was then calculated for each protein between the GFP pull-
downs and the controls. Significance of the enrichment was meas-
ured by two-sample Student’s t test assuming equal variances. Spe-
cific interaction partners were then determined in a volcano plot
where a combined threshold (hyperbolic curve) was set based on a
modified t-statistic (t(SAM, statistical analysis of microarrays); s0 
1.5, t0 0.9 1.1) (45, 46). Threshold values were chosen to balance
sensitivity and false discovery rate based on the simulation experi-
ment with spike-in standards (supplemental Fig. S2). Proteins cross-
reactive to the anti-GFP beads were identified by a pull-down assay
using N2 embryos (supplemental Fig. S1). These proteins as well as
HDA-3, a protein identified in almost all other pull-downs, have been
filtered out from the IVI data. Raw data files have been deposited on
PRIDE proteomics data repository (accession no. PXD002624).
In Vivo Interaction Proteomics
1644 Molecular & Cellular Proteomics 15.5
For SILAC pull-down experiments in mammalian cells, maximum of
3 labeled amino acids per peptide were allowed. “Requantify” option
was chosen. Only proteins quantified in both forward and reverse
experiments were considered for analysis with a minimum SILAC ratio
count set to one.
SDS-PAGE and Western Blotting—Proteins were resolved in a
NuPAGE 4–12% gradient gel (Invitrogen) and transferred to a PVDF
membrane. Blocking was done in 5% nonfat milk in TBST buffer (25
mM Tris-HCl pH 7.4, 150 mM NaCl, 0.05% (v/v) Tween-20) for 1 h,
followed by primary antibody incubation at 4 °C overnight. Primary
antibody dilutions were: 1:500 anti-CAR-1 (47), 1:500 anti-IFET-1 (48),
1:250 anti-SPN-4 (49), and 1:2,000 anti--Tubulin (Sigma-Aldrich).
The membrane was then incubated with horseradish peroxidase-
conjugated secondary antibodies (1:10,000) at room temperature for
1 h, followed by brief incubation with substrates for enhanced chemi-
luminescence (Pierce ECL Plus, Thermo Scientific, Waltham, MA).
Signal was detected by a GE Typhoon FLA 9000 biomolecular imager
at 473 nm excitation wave-length with an LPB filter.
Statistical and Network Analyses—Statistical and network analyses
were performed using R, Bioconductor and Cytoscape. GO enrich-
ment analysis for CAR-1 PPIs was conducted using the GOstats
package (50). Other enrichment analyses were done based on the
hypergeometric distribution. RNAi and GO annotations were retrieved
from WormBase release WS245. For comparison analysis with IVI,
homomeric interactions and interaction pairs containing “dead”
genes, which are no longer valid gene model entries in WS245, were
removed from the WI8 and LCI data sets. The WI8 embryo lethal
subset was based on WI8 interactions in which at least one protein of
each interacting pair is annotated with the “embryonic lethal” RNAi
phenotype. Different alternative splicing isoforms of the same gene
were collapsed into one. Interaction partners identified in two sepa-
rate GFP::MBK-2 pull-down experiments were combined. Known
interactions in IVI network were retrieved from GeneMANIA database
(version: 1 June 2014; physical interactions only) and STRING data-
base (version 10; experimental data only; evidence threshold: 0.40).
For enrichment analyses, control gene sets were generated by se-
lecting 3000 pairs of protein-coding genes at random from WormPep
(WS245). The mean percentage of gene pairs with shared RNAi
phenotypes or GO terms across 100 iterations of independent control
sets was then used for comparison with the IVI, WI8, and LCI inter-
actome data sets.
RESULTS
Quantitative Proteomics Detects Protein-Protein Interac-
tions in Worm Embryos—We reasoned that combining quan-
titative proteomics and the widely available GFP-fusion
strains should allow us to explore PPIs in C. elegans embryos
(Fig. 1 A). We first established the procedure using specific
test cases before using it to develop our initial PPI map. Our
general strategy involved collecting early C. elegans embryos
that express GFP-fusion proteins from gravid hermaphro-
dites, followed by pulling down the GFP-fusion protein (to-
gether with its interaction partners) using anti-GFP antibodies
coupled to agarose beads.
The principle of quantitative affinity purification and mass
spectrometry (q-AP-MS) is to compare the abundance of
proteins in a pull-down with a negative control (19–21). There
are two possibilities for negative controls: First, control pull-
downs can be performed with anti-GFP antibodies on worm
samples that do not express the GFP-fusion protein of inter-
est. Second, control pull-downs can be carried out with the
same worm samples that express the GFP-fusion protein but
using control beads lacking conjugated antibodies. The ad-
vantage of the second option is that the same input is used for
the experiment and the control pull-down. Therefore, results
are not affected by factors such as differences in protein
abundance between strains and variability in lysate prepara-
tion. We therefore followed this strategy and incubated the
same embryo lysate with control beads lacking conjugated
antibodies. The proteins in both pull-downs were then iden-
tified by high resolution shotgun proteomics. In order to dis-
tinguish specific interaction partners from nonspecific con-
taminants, we compared the abundance of proteins in both
pull-downs using label-free quantification. Proteins were con-
sidered specific interaction partners of the bait protein when
they were significantly more abundant in the anti-GFP pull-
downs than in controls.
Because worm proteins that were cross-reactive to the
antibody would also be enriched in the anti-GFP pull-downs,
we therefore performed additional control experiments using
the same strategy with wild-type N2 worm embryos that do
not express GFP-fusion proteins. These control experiments
revealed that the background binding profiles of anti-GFP
beads and control beads are very similar (supplemental Fig.
S1). Cross-reactive proteins that showed significant binding
to anti-GFP beads in these N2 experiments were removed
from the final sets of interaction partners for all GFP fusion
proteins.
To test the label-free quantification accuracy of our techni-
cal setup, we conducted a benchmark experiment to simulate
the detection of enriched interactions in a complex nonspe-
cific binding background (supplemental Fig. S2). We analyzed
two samples with defined protein composition that each con-
tained the same amount of E. coli whole cell lysate (to simu-
late background binders). In addition, the samples contained
a mixture of 48 different isolated or recombinant human pro-
teins (UPS2 standard) in a 1:4 ratio. Finally, four additional
recombinant proteins were exclusively spiked into one of the
two samples. We found that our method correctly identified
29 out of 32 detected differential binders. Conversely, 1174
out of 1184 background binders were correctly classified as
such. In total, the accuracy was 98.9% and the precision
90.6%. This experiment demonstrates the high accuracy and
precision of our label-free interaction proteomics approach.
To test our approach in C. elegans embryos, we targeted
the RNA-binding protein CAR-1, whose interaction with the
RNA helicase CGH-1 is evolutionarily conserved (47, 51, 52).
We pulled down GFP::CAR-1 from about 2 million transgenic
embryos in three biological replicates. We then assessed the
abundance of proteins identified in the GFP::CAR-1 pull-
downs and three control experiments performed in parallel.
We used the Student’s t test to assess which proteins were
significantly more abundant in the GFP::CAR-1 pull-downs
than in the controls. The data can be visualized in a volcano
plot that displays both the enrichment ratio and the signifi-
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cance (Fig. 1B). Specific interaction partners were then se-
lected using a combined cut-off that takes both the signifi-
cance and the enrichment ratio into account (22, 45, 46). We
determined the cut-off values to balance sensitivity and false
discovery rate based on the simulation experiment described
above. As expected, most of the 429 identified proteins had
either low enrichment ratios or high p values, indicating that
they are nonspecific contaminants. In total, 34 proteins were
significantly enriched in the GFP::CAR-1 pull-downs com-
pared with controls and were thus considered specific inter-
action partners. With the exception of ATX-2 and PATR-1, this
set of proteins contains all proteins known to interact with
both CAR-1 and CGH-1 in vivo (CEY-2, CEY-3, CEY-4,
IFET-1, PAB-1) (47, 48, 51). Thus, our strategy can capture in
vivo interactions with good sensitivity. We also observed en-
richment of Gene Ontology (GO) terms like “P granule” and
“oocyte maturation” in the interactome (Fig. 1C). This is con-
sistent with the known association of CAR-1 with P granules
and its role in oocyte development (47, 53). Interestingly, we
also observed enrichment of centrosomal proteins, which
FIG. 1. Label-free embryo interaction proteomic strategy and proof-of-concept experiment. A, Experimental design. Samples of the
same extract from worm embryos expressing GFP-protein fusions were incubated separately with anti-GFP conjugated or control beads, and
abundances of co-purified proteins were measured by mass spectrometry. B, Volcano plot showing specific interaction partners of
GFP::CAR-1 based on pull-down experiments of biological triplicate. Interaction partners meeting stringency thresholds (hyperbolic curves,
t0  0.9) are shown in red. To exemplify the effect of various stringencies, two extra curves of high cut-off (t0  2.0) and low cut-off (t0  0.5)
are drawn. Known CAR-1 interactors are colored in blue. Known P granule components detected in the pull-downs are shown in green. C, GO
term enrichment analysis for the interaction partners of GFP::CAR-1. Selected significantly enriched GO terms are displayed (conditional
hypergeometric test). D, RNAi phenotype enrichment analysis for the interaction partners of GFP::CAR-1. Selected significantly enriched RNAi
phenotypes are shown (hypergeometric test).
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may be of particular relevance to the phenotypic defects in
anaphase spindle structure and cytokinesis that are associ-
ated with depletion of CAR-1 in C. elegans embryos (52).
Similarly, when we compared known RNAi phenotypes of
CAR-1 interaction partners, we found the phenotypes “P
granule defective”, “oocyte meiotic maturation variant,” and
“cytoplasmic processing body variant” to be enriched (Fig.
1D). We also confirmed our identification of SPN-4 as a novel
CAR-1 interaction partner on Western blots using antibodies
against SPN-4 (supplemental Fig. S3). Collectively, these data
indicate that our interactome captures important aspects of
known CAR-1 biology.
The CAR-1 experiments showed that the sensitivity of the
approach can be high. However, the specificity is more chal-
lenging to determine. In addition to using stringent cut-off
values and comparing to control pull-downs, a particularly
vexing source of possible false positives might arise from
interactions that would form postlysis. This means that a bait
protein could theoretically be co-purified with proteins ex-
pressed in different tissues. We investigated this possibility
using the test case of GLD-1, a protein that is expressed only in
the germline (54). To assess the potential impact of post-lysis
interactions on our results, we mixed young adult worms ex-
pressing GLD-1::GFP with wild-type N2 worms that were met-
abolically labeled with heavy stable isotopes using SILAC, as
previously described (27). We reasoned that with this experi-
mental design (Fig. 2A), in vivo interaction partners should be
present in the light form, whereas post-lysis (i.e. in vitro)
interactions should lead to a heavy-to-light ratio of 1:1. Our
mass spectrometry data showed that peptides derived from
known GLD-1 interaction partners (55) were predominantly
detected in the light form (Fig. 2B–2F). This is particularly
remarkable given that whole worms were used for this ex-
periment, whereas GLD-1 is only expressed in the germline.
FIG. 2. Interaction proteomics detects mainly interactions formed in vivo. A, Experimental designs using in vivo SILAC. Worms harboring
GFP fusion proteins were fed on bacteria with light label (L); control N2 worms were fed on bacteria with heavy label (H). Worm lysates were
combined either prior to affinity purification with anti-GFP beads, or after independent pull-downs with anti-GFP and control beads, then the
combined samples were subjected to mass spectrometry. B–F, Representative mass spectra showing peptides of several known interaction
partners of GLD-1 (CGH-1, CAR-1, CEY-2, CEY-3, PAB-1). Preferential recovery of the light form in both treatments indicated that minimum
binding occurred post-lysis; G, the nonspecific binder, RPS-29, was identified equally in light and heavy forms. A relative increase in the heavy
form of PAB-1 when lysates were mixed prior to pulldowns suggested that PAB-1 is in dynamic exchange with a pool of free PAB-1 and/or
also binds to GLD-1 in vitro. Light peptides are shown in blue; heavy peptides are shown in red.
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Thus, our pull-down conditions appear to mainly identify
known GLD-1 interactions from pre-existing complexes that
are formed before lysis.
A Pilot Protein-Protein Interaction Network for C. elegans
Embryogenesis—Having shown that we can identify in vivo
PPIs in worm embryos, we next extended our strategy to a set
of proteins that were selected according to the following
characteristics. First, we sought established C. elegans lines
expressing GFP fusion proteins that are either capable of
rescuing loss of the endogenous gene and/or show a local-
ization pattern mirroring that of the endogenous protein in the
early embryo. Second, because we wanted to understand
how proteomics using embryos could facilitate the study of
essential developmental processes, we selected proteins with
essential functions in the C. elegans early embryo. Finally,
within the broad scope of early embryonic development, we
wanted to explore more than one biological process. We thus
included proteins involved in polarity establishment and de-
velopment (MBK-2, PAR-2, PAR-6, ZEN-4) and P granule
assembly/regulation (CAR-1, PGL-3, PIE-1). In addition, we
also included MBK-1 which is a nonessential paralog of
MBK-2 and is known to be involved in neuronal development
(29) but not in embryonic polarity. Quantitative in vivo inter-
action proteomics for all bait proteins generated a combined
network of 559 interactions between 472 proteins (Fig. 3A;
see supplemental Fig. S4 and supplemental Table S1 for a
complete list with all IDs). Considering that we only performed
pull-downs for eight bait proteins the number of detected
interactions is remarkable. Our map contains several interac-
tions known to be relevant during embryogenesis, such as the
evolutionarily conserved PAR-3/PAR-6/PKC-3 complex (10),
the binding of PAR-6 and LGL-1 (56), the interaction of PAR-2
and PAR-1 (11), the centralspindlin motor complex of ZEN-4
and CYK-4 (57), and the association of PGL-3/SEPA-1/
EPG-2, which mediates the autophagic degradation of P
granules in somatic blastomeres (58, 59). However, most of
the interactions we identified are novel.
The main value of PPI data is that it provides mechanistic
insights into biological processes. For example, because in-
teracting proteins are often involved in the same biological
pathway, inactivating the corresponding genes frequently re-
sults in the same phenotype (60, 61). In C. elegans, RNAi
FIG. 3. Embryo in vivo interactome (IVI) map and enrichment of shared functions for IVI partners. A, Embryo IVI map. Bait (orange) and
prey (pink) proteins are shown as nodes sized proportionally to their degree distribution. Edges for known interactions are colored according
to STRING database (green), GeneMANIA database (magenta) or both (brown). Thickness of the edges is weighted based on the t (SAM)
statistic (See supplemental Fig. S4 for high-resolution network diagram.) B, Stacked bar charts showing the percentages of interacting protein
pairs that share at least one annotated RNAi phenotype or Biological Process GO term for IVI, WI8, WI8 subset (at least one protein of each
interacting pair is annotated with the “embryonic lethal” RNAi phenotype) and LCI versus random sets of gene pairs (percentages are mean
values based on 100 random samples of size 3,000 from all protein-coding genes).
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phenotypes provide a valuable resource to assess the func-
tional relationship between genes in vivo. To test the func-
tional relevance of our in vivo interactome (IVI) data, we there-
fore analyzed the proportion of interacting proteins that share
RNAi phenotypes. Intriguingly, we found that more than 50%
of all PPIs in IVI have at least one RNAi phenotype that is
shared between both proteins (Fig. 3B). This fraction is about
10 times higher than expected for random protein pairs ( 5%
in 100 control sets). For comparison, we repeated this anal-
ysis for yeast two-hybrid-based data (worm interactome ver-
sion 8, WI8) and literature curated interactions (LCI) (6). We
found that the fraction of PPIs with shared RNAi phenotypes
in IVI is on par with LCI and considerably higher than in WI8.
Our bait proteins were selected based on their essential func-
tion in early embryogenesis. To compensate for this selection
bias, we also restricted the WI8 data set to interactions where
at least one protein of each pair is annotated with the “em-
bryonic lethal” RNAi phenotype. We found that IVI still out-
performs this “WI8 embryonic lethal” subnetwork. Similar re-
sults were obtained for shared GO terms (Fig. 3B). In
summary, these analyses strongly support the high biological
relevance of our in vivo interactome data.
Identification of the MBK-2 Binding Partner GEI-12 as a
Novel Protein Required for P Granule Assembly—Having
shown that our in vivo interaction map contains functionally
relevant information, we next asked if these data would allow
us to better understand embryonic development. To this end,
we focused on P granule assembly. Like other types of RNP
granules, P granules are microscopically visible assemblies of
RNAs and proteins (62). Mutations in genes encoding P gran-
ule components often cause sterility, indicating that they are
key determinants of germ cell identity (12). In the one-cell
embryo, P granules are initially distributed evenly throughout
the cytosol. Before the first cell division, they localize to the
posterior half of the zygote and subsequently segregate with
the P lineage. Microscopic studies have shown that P gran-
ules are highly dynamic and show liquid-like behavior (13).
However, the molecular signaling mechanisms that regulate
assembly and disassembly of RNP granules (including P gran-
ules) have not been completely elucidated.
MBK-2, a member of the dual-specificity tyrosine-regulated
kinase (DYRK) family, is an important regulator of the oocyte-
to-embryo transition (reviewed in 63) that also influences P
granule assembly (30, 64). We confirmed this finding by per-
forming time lapse microscopy in GFP::PGL-3 embryos
(supplemental Movie S1 and S2): while control RNAi embryos
showed the expected segregation of P granules to the P
lineage, mbk-2(RNAi) animals displayed ectopic granules in
somatic blastomeres. We asked if our PPI data for MBK-2
could help us to characterize its role in P granule assembly in
vivo. Before fertilization, MBK-2 is sequestered at the oocyte
cortex via interaction with the cortical anchors EGG-3 and the
pseudo-phosphatases EGG-4/5 (65–67). Consistently, we
detected binding of MBK-2 with EGG-3/4 and CHS-1, a pro-
tein involved in egg shell synthesis (68). Interestingly, we also
detected as MBK-2 interaction partners several known P
granule components, i.e. CCF-1, GLD-2/3, DRH-3, and
MEG-2.
Because most of the interaction partners we identified for
MBK-2 had no known role in P granule assembly, we inves-
tigated whether any of them also showed a P granule pheno-
type in embryos, using RNAi knock-downs with GFP::PGL-1
and GFP::PGL-3 as P granule markers. Of 40 genes tested,
depletion of only one - gei-12 - displayed a discernible P
granule phenotype (Fig. 4). In embryos, knocking down gei-12
disrupted the localization of both PGL-1 and PGL-3 to P
granules: while control embryos showed proper segregation
of these markers to the P lineage, gei-12(RNAi) embryos
displayed diffuse GFP signal throughout all cells and lacked
detectable granule formation in the germline progenitor.
These results were also confirmed by antibody staining
against endogenous P granule proteins (supplemental Fig.
S5).
P granule assembly has previously been shown to involve a
hierarchy of genetic components (12). We investigated the
role of gei-12 in this hierarchy and found that recruitment of
GLH-1, a protein that acts upstream of PGL-1 and PGL-3 in P
granule assembly (12, 69), was also impaired by RNAi
of gei-12 (Fig. 4). Thus, gei-12 acts upstream of pgl-1/3 and
glh-1 in the hierarchy of P granule assembly in the early
embryo. We also found that gei-12 is required for the enrich-
ment of MBK-2 in the P lineage (Fig. 4). However, several
other posteriorly localized components such as CAR-1, PIE-1,
POS-1 and SPN-4 still segregated properly when gei-12 was
depleted (supplemental Fig. S6). Therefore, gei-12 is needed
to recruit a distinct subset of P granule components, including
PGL-1/3, GLH-1 and MBK-2, but is dispensable for the asym-
metric localization of other proteins. Finally, our results indi-
cate that gei-12 is specifically required for P granule assembly
in the embryo, because its depletion did not detectably dis-
rupt the formation or localization of P granules in the parental
germline of adult RNAi-treated worms (Fig. 4). Next, to inves-
tigate the localization of GEI-12 in embryos, we created a
transgenic GEI-12::GFP line. We observed a perinuclear pat-
tern in the developing germline and granular structures in the
cytoplasm of maturing oocytes (Fig. 5A). In embryos,
GEI-12::GFP localized to the posterior at the one-cell stage
and segregated with the P lineage as embryonic cell division
progressed. Thus, the distribution of GEI-12 resembles that of
P granules in early development.
GEI-12 has two known paralogs, C36C9.1 and F52D2.12.
To further characterize the function of these paralogs, we
performed additional experiments to investigate their poten-
tial roles and functional redundancy in P granule assembly.
When we stained P granules using antibodies in available
lines harboring mutations in these genes, we found that nei-
ther of two gei-12 deletion mutant strains (tm4526 and
tm4259) showed a P granule phenotype, nor did the C36C9.1
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mutant strain (tm4343) (supplemental Fig. S7). Knocking
down C36C9.1 and F52D2.12 individually by RNAi in wild-
type animals also did not impair P granule assembly
(supplemental Fig. S5). Combined with our gei-12(RNAi) re-
sults, which did show a P granule phenotype, it appears that
the paralogs of gei-12 are efficiently targeted by the gei-12
RNAi clone, and that there is some functional redundancy
among them. Indeed, the gei-12 RNAi clone shows a high
degree of sequence similarity with C36C9.1 and F52D2.12.
When we tested the functional significance of this, we found
that knocking down C36C9.1 in either gei-12 mutant strain
disrupted P granule assembly with higher penetrance than in
wild-type worms (supplemental Fig. S7). From these experi-
ments, we conclude that gei-12 and its paralogs are critically
involved in P granule assembly in a partially redundant
manner.
GEI-12 is Required for Germline Maintenance—Compro-
mising multiple P granule components simultaneously has
been reported to produce sterility after more than one gener-
ation of RNAi (70). In a similar fashion, L1 larvae treated with
gei-12 RNAi initially remained fertile upon reaching adulthood;
however, continuous application of gei-12 RNAi to the prog-
eny by feeding resulted in sterility in about 5% of the F1
generation and up to 30% of the F2 generation at 15 °C, and
these percentages increased up to 35 and 68% when the test
was performed at 25 °C (Fig. 6A). Sterile worms had empty
uteri and extremely reduced germlines with no gametes, both
in hermaphrodites and in males (Fig. 6B–6C). We conclude
that gei-12 is an important maternally provided germline fac-
tor that is required in the embryo for fertility and germline
proliferation, and that this requirement increases with temper-
ature. Similar findings were previously reported for the P-
granule components meg-1 and meg-2 (71).
GEI-12 Forms Granules in Mammalian Cells—GEI-12 does
not have clear orthologs outside nematodes, nor does it have
predicted protein domains. The protein is remarkably rich in
serine and threonine residues (20%) and contains several
predicted low complexity (LC) regions (Fig. 5B). Recently, LC
regions have been reported to be both necessary and suffi-
cient for RNP granule formation in a cell free system (72). We
therefore wondered if GEI-12 can itself induce granules in the
absence of other C. elegans factors. To test this possibility,
we expressed EGFP::GEI-12 in HEK293T cells. Indeed, we
observed the formation of multiple fluorescent granules (Fig.
7A). Thus, GEI-12 can drive granule formation in mammalian
cells, similar to previous observations for PGL-1/3 (73). To
further characterize these GEI-12-positive granules in
HEK293T cells, we used SILAC-based quantitative interaction
proteomics to identify specific interaction partners (19, 20).
We found that EGFP::GEI-12 specifically interacted with
nearly 300 mammalian proteins (Fig. 7B). Most of these pro-
teins are well-known RNA binding proteins such as FXR-1/2,
FIG. 4. GEI-12 is a novel protein required for P granule assembly. Depletion of gei-12 by RNAi affected P granule assembly specifically
during early embryogenesis but not prior to fertilization, as visualized in live embryos harboring GFP fusions of several proteins that localize
to P granules. L4440(RNAi) served as control.
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Staufen, translation initiation factors and ribosomal proteins.
About 10% of these proteins are known components of dif-
ferent types of RNP granules (72), which represents a highly
significant enrichment (p value  6  1021, hypergeometric
test). A notable additional class of proteins were components
of the protein phosphatase 2A (PP2A) family (discussed be-
low). Thus, GEI-12 positive granules contain many known
mammalian RNP granule components. This is surprising, es-
pecially because GEI-12 has no known mammalian ortholog.
Combined with the observations that GEI-12 is (1) required for
P granule formation in worms, and (2) forms granules in mam-
malian cells, our results suggest that this protein plays a
functionally conserved role in the assembly of RNP granules,
and that the primary determinant of this activity resides in
physical properties of the protein. Most of the proteins co-
purifying with GEI-12 are not affected by nuclease treatment,
suggesting that they are not RNA dependent (Fig. 7C).
Kinase and Phosphatase Interplay Regulates P Granule As-
sembly During Early Embryogenesis—The molecular signaling
mechanisms that regulate the assembly and disassembly of
RNP granules (including P granules) are not entirely under-
stood. mbk-2(RNAi) embryos displayed ectopic granules out-
side the germline ((30), Fig. 8 and supplemental Movie S2). In
mammals, dissolution of stress granules is driven by DYRK3,
a homolog of MBK-2 (74). Hence, the kinases DYRK3 and
MBK-2 might induce granule dissolution by phosphorylating
specific substrates. In this context, it is particularly intriguing
that we identified several proteins belonging to the PP2A
family of phosphatases as GEI-12 interaction partners in
mammalian cells (Fig. 7B). This set of proteins included the
catalytic subunit (PPP2CA), structural subunits (PPP2R1A,
PPP2R1B) and, specifically, several regulatory subunit B56
subfamily members (PPP2R5A, PPP2R5C, PPP2R5E). This is
significant because, in our MBK-2 pull downs, we also iden-
FIG. 5. GEI-12 forms granules in vivo and segregates exclusively with the P lineage. A, Transiently expressed GEI-12::GFP formed
granules in vivo in the adult germline and zygote, and these segregated to the P lineage during early embryogenesis in a localization pattern
resembling that of P granules. B, The sequence of GEI-12 contains several predicted low complexity regions (highlighted in magenta) and a
high proportion of serine/threonine residues (19.4%, highlighted in green). Prediction was performed in SMART database using the SEG
algorithm with default parameters (82).
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tified PPTR-2, a C. elegans ortholog of the B56 subfamily
(supplemental Fig. S4 and supplemental Table S1). PPTR-2
has also been reported to physically interact with GEI-12 and
its paralog C36C9.1 in yeast two-hybrid screens (6). More-
over, another worm ortholog of the B56 subfamily, pptr-1, has
previously been shown to be required for P granule assembly
(75). In fact, the phenotypes of pptr-1 mutants and gei-
12(RNAi) worms are strikingly similar. We therefore tested if
depleting mbk-2 could rescue the P granule phenotype of
pptr-1 mutant embryos. As previously described (75), we
observed that pptr-1 mutant embryos showed strongly re-
duced P granules at the one- and two-cell stages that further
diminished during embryonic cell divisions (Fig. 8). Intrigu-
ingly, knocking down mbk-2 by RNAi restored P granule for-
mation in the pptr-1 mutant (Fig. 8). Hence, mbk-2 and pptr-1
appear to mediate P granule dissolution and formation, re-
spectively. Taken together, these findings strongly suggest
that GEI-12 may orchestrate the dynamics of P granules by
interacting with the kinase MBK-2 and the phosphatase
PP2A.
DISCUSSION
Identifying interaction partners in the context of a living
animal is arguably the most informative single data set to
characterize protein function. Very few studies have reported
the systematic isolation of interaction partners in animal tis-
sues for multiple bait proteins (76), and no such studies have,
to our knowledge, been performed using isolated C. elegans
embryos. To the best of our knowledge, our initial network of
559 interactions among 472 proteins represents the first in
FIG. 6. GEI-12 is required for germline pro-
liferation and gamete formation. A, Left: Pro-
tocol for continuous generational RNAi of gei-12
by feeding. Right: Average sterility rates among
adult progeny in first (F1) and second (F2) filial
generations, with standard error. Adults from the
P0 generation were not sterile; sterility among
adult progeny increased with generation and
temperature. B–C, Examples of adult hermaph-
rodite (B) and male (C) progeny after generational
gei-12(RNAi) treatment. Light micrographs (left)
and GFP::PGL-1 (right) show reduced germlines
with fewer PGL-1 positive cells in both sexes.
Sterile hermaphrodites also show empty uteri de-
void of embryos. Bottom panels in (B) show mag-
nified view of highlighted boxes in upper panels.
In (C), bracket spans region of defective male
germline.
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vivo interactome (IVI) during C. elegans embryogenesis. De-
spite the limited scale, our unbiased data contain several
previously described interactions and thus reflect known bi-
ology. More importantly, the high fraction of shared RNAi
phenotypes among interaction partners demonstrates that
our network also predicts protein function.
The comparison with yeast two-hybrid studies indicates
that our in vivo interactome mapping approach provides data
with higher functional relevance. As with any experimental
approach, however, it is important to be cognizant of techni-
cal limitations. Most importantly, GFP-fusion proteins may be
expressed at different levels and/or may not fully recapitulate
the functions of their endogenous counterparts. Although the
first issue can be addressed by expressing transgenes under
endogenous cis regulatory control (77), the GFP tag—like any
other tag—might still affect in vivo protein function. Using
transgenes that can rescue loss-of-function phenotypes
should help to minimize this caveat. Next, the potential intro-
duction of artifacts during biochemical purification could be
limited by crosslinking samples in situ prior to lysis; even
though our controls indicated that post-lysis interactions were
negligible in at least one test case, we cannot rule out the
possibility that some post-lysis PPIs may be recovered in
assays with different fusion proteins. Finally, our current IVI
mapping strategy is relatively low throughput because we
perform experiments using one bait protein at a time. This
may not be a major limitation in practice, given the fact that
we generated interaction data for almost 500 proteins using
pull-down experiments with only eight bait proteins. This
might be because of the central function these proteins play in
embryogenesis. Performing similar experiments with 100
selected “hub” baits would probably cover a substantial frac-
tion of the worm interactome. It is possible to envision future
improvements to IVI mapping approaches that would enable
the simultaneous interrogation of multiple bait proteins, which
could significantly enhance throughput.
RNP granules have emerged as important players in the
post-transcriptional regulation of gene expression in many
organisms (78). Like other membraneless compartments, or
organelles, they resemble liquids that form by phase separa-
tion from the cytoplasm (79, 80). C. elegans P granules are
probably the most extensively characterized in vivo model for
RNP granules (12). Although genetic analysis has placed
several P granule components into an assembly pathway
(DEPS-13 GLH-13 PGL-1/33 IFE-1), the cellular signaling
events that mediate granule formation are still incompletely
understood. Time-lapse microscopy has shown that localiza-
tion occurs via condensation of the liquid-like P granules at
the posterior and dissolution at the anterior (13). Dissolution
correlates with the levels of the polarity protein MEX-5, which
is concentrated in the anterior of the one-cell embryo, sug-
gesting that MEX-5 promotes the posterior localization of P
granules by promoting their dissolution in the anterior. The
activity of MEX-5 and the closely related MEX-6 are regulated
by polo-like kinases (PLK-1/2), and this interaction is strongly
enhanced by MBK-2 as the priming kinase (81). On the other
hand, PPTR-1, a regulatory subunit of the protein phospha-
tase PP2A, is specifically required for embryonic P granule
assembly during mitosis (75). These data indicate that P gran-
ule dynamics are regulated by the interplay of kinases
(MBK-2, PLK-1/2) and phosphatases (PP2A/PPTR-1), but
how these activities are coordinated mechanistically is un-
clear.
FIG. 7. GEI-12 forms granules in mammalian cells and interacts with RNA-binding proteins and PP2A. A, EGFP::GEI-12 expressed in
HEK293T cells forms granules (top), whereas control cells expressing EGFP only do not (bottom). DAPI staining shown in blue. B, Label-swap
SILAC pull-downs of EGFP::GEI-12 in HEK293T cells. The majority of interacting proteins are annotated with the GO term “RNA binding”. Other
interactors include known RNP granule components and multiple PP2A subunits (catalytic subunit, structural subunits, and several regulatory
subunit B56 subfamily members). C, SILAC pull-down of EGFP::GEI-12 in HEK293T lysates comparing with (H) and without (L) nuclease
pre-treatment. The majority of GEI-12 interactions remained unaltered upon nuclease treatment, suggesting that they are not RNA dependent.
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Here, we identified GEI-12 and its paralog as novel regula-
tors of P granule dynamics and germline competence. First,
we found that GEI-12 co-purified with MBK-2 and PPTR-2.
Second, we observed that the protein localizes to the P line-
age and is required for granule assembly and maintenance of
the germline. Third, we found that GEI-12 forms granules in
mammalian cells and interacts with RNA binding proteins and
PP2A family proteins. Finally, we observed that knocking
down mbk-2 restores P granule formation in the pptr-1 mu-
tant. Recently, binding between GEI-12 and PPTR-1, the loss-
of-function phenotypes of gei-12 in P granule assembly and
fertility, and the suppression of pptr-1 mutant phenotype by
mbk-2(RNAi) were also independently reported by Wang et al.
(25). In addition, we show that GEI-12, MBK-2, and PPTR-2
physically interact and that GEI-12 forms granules in mam-
malian cells.
The emerging model from our study is that P granule as-
sembly and disassembly may be regulated by dephosphoryl-
ation and phosphorylation, respectively, of GEI-12 and its
paralog. In this scenario, unphosphorylated GEI-12 may serve
as a scaffold for the assembly of additional P granule com-
ponents. Nonetheless, despite the physical and genetic inter-
action data, the current study lacks direct evidence to dem-
onstrate a kinase/phosphatase/substrate relation. Recent
findings from the Seydoux lab (25) revealed that MBK-2 can
phosphorylate GEI-12 in vitro, and that the in vivo phosphory-
lation level of the protein is affected by MBK-2 and PPTR-1. In
addition, we show that (1) MBK-2 physically interacts with
both GEI-12 and PPTR-2, and (2) GEI-12 forms granules when
expressed in mammalian cells. Our finding that granules in-
duced by GEI-12 in mammalian cells are rich in known RNP
granule components, and that they also contain catalytic,
structural and regulatory subunits of the PP2A family of phos-
phatases, suggest that the fundamental mechanisms of gran-
ule assembly are conserved between worms and humans. It
would therefore be very interesting to test if PP2A stabilizes
RNP granules in mammals. Coupled with the fact that GEI-12
has no obvious mammalian counterparts, but that it is rich in
low complexity (LC) regions and potential serine/threonine
phosphorylation sites (nearly 20% of residues in GEI-12 are
Ser or Thr), it is possible that RNP granule formation in vivo is
regulated by bulk biochemical properties of these aggregates
rather than sequence-specific molecular interactions. Be-
cause of the highly negatively charged nature of RNA, it would
thus be expected that dissolution of RNP granules would be
driven by state transitions between lowly and highly phosphory-
lated forms of putative scaffold proteins like GEI-12. This idea
is fully consistent with previous discoveries on the liquid-like
behavior of RNP granules and the ability of LC-rich proteins to
form spontaneous aggregates in solution (13, 72).
In summary, our data show that in vivo interaction proteo-
mics provides unique insights into animal development. The in
vivo nature of this approach also produces data with a higher
functional relevance than classical methods. Although a major
strength of C. elegans has traditionally been its utility for
genetic analysis, our work demonstrates that this model or-
FIG. 8. Depletion of mbk-2 by RNAi restores
P granule formation in pptr-1 mutant em-
bryos. P granules do not segregate normally to
the posterior because of loss of cell polarity upon
mbk-2 depletion. Knocking down mbk-2 leads to
missegregation of P granules in wild-type N2 em-
bryos. L4440(RNAi) served as control.
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ganism is also well suited for systematic biochemical analysis
of protein-protein interactions. Combined with the recent gen-
eration of genome-wide collections of GFP fusion constructs
(77), we expect the quantitative approach using C. elegans
embryos to become a valuable orthogonal tool both to un-
cover new biology and to deepen our understanding of uni-
versal mechanistic principles using this animal model system.
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